WESTFIELD, Ind. – A Westfield mom is about to enter a new world of politics as Indiana lawmakers return to the Statehouse in January. And the only story she’s bringing with her is the one of her 2-year-old son Graham.
Graham was born with spinal muscular atrophy, a rare and oftentimes deadly condition where muscles become too weak to perform basic functions like walking, talking, eating or drinking.
Multiple times a day, Graham undergoes treatment.
“It’s gentle,” Graham’s mom Adrienne Vollmer said. “It just mobilizes secretions in his chest.”
Graham was diagnosed with SMA when he was two months old. But two months is often too late.
“We were really just told there’s no treatment, there’s no cure,” Vollmer said. “You can take him home and love him.”
SMA is not one of the 47 conditions newborn babies are tested for in Indiana.
But Vollmer and State Rep. Douglas Gutwein (R-Francesville) are working to change that. Gutwein is writing legislation for the upcoming session that would add spinal muscular atrophy to the list.
“We’re going to save babies lives,” Gutwein said. “It’s as simple as that.”
Gutwein said preliminary fiscal estimates indicate the cost estimated at $890,000 for the first year, which would include testing and equipping the lab that handles newborn screenings.
“Lawmakers are going to have a decision to make on this,” Vollmer said. “They’re going to have an ability to vote yes or vote no.”
Graham is part of a clinical trial in Chicago with Spinraza, the first-ever drug that was FDA approved a year ago. Vollmer said the clinical trials showed the drug is most effective for babies who had yet to show any symptoms.
“We’re fighting for those families because we can change the face of the future for their children,” Vollmer said. “And if I can prevent another mom and dad from going through what my husband and I went through, not to mention for the children to be able to keep their ability to walk and move and swallow and breathe and survive, it’s worth it.”